Clinical trials: Breast Cancer, Female
Breast Cancer Female, Triple Negative Breast Cancer
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism
breast cancer is the most common cancer in women. With more than 1 in 10 new cancer diagnoses each year, It is the second most frequent cancer-related death among women worldwide.
- Trial name
- NCT05680662
- Testing
- quercetin, EGCG, metformin , zinc
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Ministry of Health, Saudi Arabia
Breast Cancer Female
Prone Breast Radiotherapy Treatment Planning Observational Study
The study purpose is to evaluate whether or not clinical characteristics of women with breast cancer can predict which position for radiation treatment, prone or supine, will be associated with a dosimetry gain.
- Trial name
- HUGProne (NCT02237469)
- Testing
- Prone and supine simulation
- Where
- Switzerland
- Volunteers
- 280 people
- Sponsor
- Vincent Vinh-Hung
Breast Cancer Female, Leptomeningeal Metastases
BATs in Patients With Breast Cancer and Leptomeningeal Metastases
This study uses bi-specific antibody (HER2Bi) armed activated T-cells (HER2 BATs) to target breast cancer cells that have metastasized to the membranes surrounding the brain and spinal cord.
- Trial name
- NCT03661424
- Testing
- HER2 BATs
- Where
- United States
- Volunteers
- 3 people
- Sponsor
- University of Virginia
Female Patients Under the Age of 65 Who Will Undergo Breast Cancer Surgery
The Effect of Premedication on Postoperative Pain and Anxiety in Breast Cancer Surgery
In this study, it was investigated whether the premedication drug administered before the surgery had an effect on postoperative pain and anxiety scores in female patients under the age of 65 who will undergo breast cancer…
- Trial name
- NCT05647642
- Testing
- Precedex and dormicum
- Where
- Turkey (Türkiye)
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Breast Cancer Female
Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF
In the study, subjects will scheduled to undergo four 21-days cycles of chemotherapy treatment. Three group were treated with MW05 300 μg/kg or MW05 500 μg/kg or PEG-rhG-CSF 100 μg/kg on the 3th day of each cycle randomized 1:1:1…
- Trial name
- NCT04554056
- Testing
- MW05, PEG-rhG-CSF
- Where
- China
- Volunteers
- 586 people
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
Breast Cancer Female
CARdiac Function Evaluation in Breast Cancer Patients
This study will investigate the influence of systemic adjuvant/neoadjuvant therapy (SAT: chemotherapy +/- anti-HER2 antibodies (trastuzumab +/- pertuzumab) on heart function/rhythm and cardio-respiratory fitness in recently…
- Trial name
- CARE-B (NCT03266809)
- Where
- United Kingdom
- Volunteers
- 17 people
- Sponsor
- Swansea University
Breast Cancer Female, Triple Negative and Androgen Receptor Positive
Study on Androgen Receptor and Triple Negative Breast Cancer
This is a multicenter uncontrolled, open-label, prospective, non-comparative randomized, phase II study. Patients will be randomized between darolutamide in Arm n°1 (two-stage Simon's design) and capecitabine in Arm n°2 with two…
- Trial name
- START (NCT03383679)
- Testing
- Darolutamide, Capecitabine
- Where
- France
- Volunteers
- 94 people
- Sponsor
- UNICANCER
Breast Cancer Female, Inflammation
Fruit and Vegetable Intervention in Lactating Women to Reduce Breast Cancer Risk
Mechanistic data show that compounds in fruits and vegetables have anti-inflammatory and anti-carcinogenic properties that can reduce breast cancer risk.
- Conditions
- Breast Cancer Female, Inflammation, Postpartum Weight Retention, Diet, Healthy
- Trial name
- NCT04374747
- Testing
- Dietary Counseling
- Where
- United States
- Volunteers
- 400 people, healthy volunteers welcome
- Sponsor
- University of Massachusetts, Amherst
Anxiety, Stress
A New Mindfulness Intervention Called Mindfulness Based Swinging Technique (MBST) for Women With Breast Cancer
It is hypothesised to find that the new mindfulness intervention of Mindfulness Based Swinging Technique (MBST) for Women With Breast Cancer is an effective therapeutic intervention to be applied in breast cancer population.
- Conditions
- Anxiety, Stress, Self Efficacy, Depression
- Trial name
- NCT03985267
- Testing
- Mindfulness based Swinging Effect Intervention
- Where
- 2 sites in Turkey (Türkiye)
- Volunteers
- 156 people
- Sponsor
- University of Barcelona
Breast Cancer Female
Effect of Heavy-load Resistance Training During Chemotherapy on Muscle Cellular Outcomes
(Neo-)adjuvant chemotherapy for breast cancer is known to have a negative impact on muscle tissue resulting in reduced aerobic fitness, skeletal muscle mass and strength.
- Trial name
- NCT04586517
- Testing
- Heavy-load resistance training, Control
- Where
- Sweden
- Volunteers
- 40 people
- Sponsor
- Uppsala University
Breast Cancer Female
The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer
This study aims at evaluating and comparing the anti-tumor effects of metformin and statins (hydroxyl-methyl-glutaryl-CoA reductase inhibitors) in patients with non-metastatic breast cancer (stage I, II, \& III).
- Trial name
- NCT05507398
- Volunteers
- 100 people
- Sponsor
- Tanta University
Breast Neoplasm Female, Breast Reconstruction
Axillary Versus Primary Breast Approach for Second-stage Breast Reconstruction
The goal of this clinical trial is to compare the safety of axillary or primary breast approach for second-stage operation in expander-implant breast reconstruction for breast cancer patients.
- Conditions
- Breast Neoplasm Female, Breast Reconstruction, Wound Complication
- Trial name
- AvBSR (NCT05600153)
- Testing
- implant exchange operation
- Where
- China
- Volunteers
- 136 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Breast Cancer Female
A Feasibility Study of the Bone@BC App Version 3.0
Introduction Due to improvements in diagnostics and treatments, the 5-year survival for patients with breast cancer is 80-90% after initial diagnosis.
- Trial name
- Believe@BC (NCT05367830)
- Testing
- the Bone@BC app
- Volunteers
- 50 people
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
Breast Neoplasm Female
Diagnosis Value of SEMA4C in Breast Cancer
Breast cancer remains the most common cancer in women worldwide. Early diagnosis can greatly improve the prognosis. To date, imaging examination is still the most important diagnostic and grading tool for breast cancer.
- Trial name
- NCT03662633
- Testing
- Breast cancer group, Benign breast tumor group
- Volunteers
- 2,300 people
- Sponsor
- Tongji Hospital
Breast Cancer Female
Blue Note Therapeutics Product BNT 103 Usability and User Engagement
This test aims to explore product development-focused usability and user engagement.
- Trial name
- NCT05032404
- Testing
- BNT103
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Blue Note Therapeutics
Breast Neoplasm Female
Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer
This study investigates the efficacy and safety of trastuzumab, pyrotinib combined with dalpiciclib and endocrine therapy for patients with advanced HR+/HER2+ brest cancer, providing more possible effective regimens for the…
- Trial name
- NCT05577442
- Testing
- Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy
- Volunteers
- 52 people
- Sponsor
- Peking University Cancer Hospital & Institute
Female Breast Cancer
Ultra-hypofractionated Radiotherapy in Breast Cancer Patients
The present multicenter, retrospective and prospective observational study, aims to evaluate an ultra-hypofractionated whole breast irradiation schedule (WBI, 26 Gy in 5 fractions), in order to confirm literature data (FAST-F…
- Trial name
- NCT05586256
- Testing
- ultra-hypofractionated whole breast irradiation
- Where
- Italy
- Volunteers
- 300 people
- Sponsor
- University Of Perugia
Breast Cancer Female, Genitourinary Syndrome of Menopause
MonaLisa Laser Intervention for Post-Menopausal Breast Cancer Patients: A SHE CAN Study
The purpose of this study is to assess the efficacy of a fractional CO2 laser ("SmartXide2 - V2LR", DEKA M.E.L.A., Florence - Italy) "the Laser" in the treatment of genitourinary symptoms of menopause, female sexual function, and…
- Trial name
- NCT04606550
- Testing
- Microablative Fractional CO2 Laser Therapy
- Sponsor
- Mount Sinai Hospital, Canada
Breast Cancer Female
In Vitro Detection of Tissue Abnormality
Intraoperative ex-vivo use of the ClearEdge Imaging Device in Breast Conserving Surgery to image the excised tissue surgical margins.
- Trial name
- NCT01209182
- Testing
- Testing a new device (LS BioPath TOUCH) on excised tissue
- Where
- United States
- Volunteers
- 121 people
- Sponsor
- LS BioPath
Breast Cancer Female, Side Effects
Rehabilitation Through Hippotherapy for the Management of Women After Primary Treatment of Breast Cancer
Breast cancer is the most common women's cancer and the third leading cause of death. Advances in prevention, detection and primary treatment have improved overall survival leading to its growing acceptance as a long-term…
- Conditions
- Breast Cancer Female, Side Effects, Psychological Distress, Physical Disability
- Trial name
- HippoBreastCa (NCT04350398)
- Testing
- Hippotherapy, Conventional therapy
- Where
- France
- Volunteers
- 83 people
- Sponsor
- Alliance Equiphoria